Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1958 1
1959 2
1960 1
1963 1
1964 1
1965 1
1995 1
1998 1
2002 1
2003 1
2011 1
2015 2
2020 2
2021 2
2022 2
2023 4
2024 8
2025 11

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

43 results

Results by year

Filters applied: . Clear all
Page 1
Prenatal cfDNA Sequencing and Incidental Detection of Maternal Cancer.
Turriff AE, Annunziata CM, Malayeri AA, Redd B, Pavelova M, Goldlust IS, Rajagopal PS, Lin J, Bianchi DW. Turriff AE, et al. Among authors: redd b. N Engl J Med. 2024 Dec 5;391(22):2123-2132. doi: 10.1056/NEJMoa2401029. N Engl J Med. 2024. PMID: 39774314 Free PMC article.
Multiomics analysis of immune correlatives in hepatocellular carcinoma patients treated with tremelimumab plus durvalumab.
Myojin Y, Babaei S, Trehan R, Hoffman C, Kedei N, Ruf B, Benmebarek MR, Bauer KC, Huang P, Ma C, Monge C, Xie C, Hrones D, Duffy AG, Armstrong P, Kocheise L, Desmond F, Buchalter J, Galligan M, Cantwell C, Ryan R, McCann J, Bourke M, Mac Nicholas R, McDermott R, Awosika J, Cam M, Krebs R, Budhu A, Revsine M, Figg WD, Kleiner DE, Redd B, Wood BJ, Wang XW, Korangy F, Claassen M, Greten TF. Myojin Y, et al. Among authors: redd b. Gut. 2025 May 7;74(6):983-995. doi: 10.1136/gutjnl-2024-334026. Gut. 2025. PMID: 39965889 Free PMC article. Clinical Trial.
The Role of Multiparametric Magnetic Resonance Imaging and the Vesical Imaging-Reporting and Data System (VI-RADS) in the Management of Patients with Bladder Cancer: Vision of the American College of Radiology VI-RADS Steering Committee.
Panebianco V, Briganti A, Efstathiou J, Galgano S, Luk L, Muglia VF, Redd B, de Rooij M, Takeuchi M, Woo S, Witjes JA, Vargas HA. Panebianco V, et al. Among authors: redd b. Eur Urol. 2024 Dec;86(6):485-487. doi: 10.1016/j.eururo.2024.09.013. Epub 2024 Sep 23. Eur Urol. 2024. PMID: 39317635
Final Results From a Phase I Trial and Expansion Cohorts of Cabozantinib and Nivolumab Alone or With Ipilimumab for Advanced/Metastatic Genitourinary Tumors.
Apolo AB, Girardi DM, Niglio SA, Nadal R, Kydd AR, Simon N, Ley L, Cordes LM, Chandran E, Steinberg SM, Lee S, Lee MJ, Rastogi S, Sato N, Cao L, Banday AR, Boudjadi S, Merino MJ, Toubaji A, Akbulut D, Redd B, Bagheri H, Costello R, Gurram S, Agarwal PK, Chalfin HJ, Valera V, Streicher H, Wright JJ, Sharon E, Figg WD, Parnes HL, Gulley JL, Saraiya B, Pal SK, Quinn D, Stein MN, Lara PN, Bottaro DP, Mortazavi A. Apolo AB, et al. Among authors: redd b. J Clin Oncol. 2024 Sep 1;42(25):3033-3046. doi: 10.1200/JCO.23.02233. Epub 2024 Jul 2. J Clin Oncol. 2024. PMID: 38954785 Free PMC article. Clinical Trial.
Altering the gut microbiome and tumor microenvironment in advanced liver cancer: A phase II study of nivolumab, tadalafil and oral vancomycin in patients with refractory primary hepatocellular carcinoma or liver dominant metastatic cancer from colorectal or pancreatic cancers.
Ma C, Awosika JA, Monge C, Coffman-D'Annibale K, Xie C, Skorupan N, Hrones DM, Liu M, Ma L, Wood BJ, Levy EB, Kleiner DE, Figg WD, Redd B, McCulloch JA, Fernandes MR, Trinchieri G, Greten TF. Ma C, et al. Among authors: redd b. Cancer Lett. 2025 Nov 1;632:217975. doi: 10.1016/j.canlet.2025.217975. Epub 2025 Aug 9. Cancer Lett. 2025. PMID: 40789510 Clinical Trial.
The CHK1 inhibitor prexasertib in BRCA wild-type platinum-resistant recurrent high-grade serous ovarian carcinoma: a phase 2 trial.
Giudice E, Huang TT, Nair JR, Zurcher G, McCoy A, Nousome D, Radke MR, Swisher EM, Lipkowitz S, Ibanez K, Donohue D, Malys T, Lee MJ, Redd B, Levy E, Rastogi S, Sato N, Trepel JB, Lee JM. Giudice E, et al. Among authors: redd b. Nat Commun. 2024 Mar 30;15(1):2805. doi: 10.1038/s41467-024-47215-6. Nat Commun. 2024. PMID: 38555285 Free PMC article. Clinical Trial.
E-VIRTUE: a study of enfortumab vedotin with or without pembrolizumab in rare genitourinary tumors-design and rationale.
Chandran EBA, Atiq S, Simon N, Girardi D, Ley L, Cordes L, Patel R, Wang TF, Kydd AR, Redd B, Boudjadi S, Stukes I, Banday R, Smith E, Akbulut D, Niglio S, Gurram S, Steinberg S, Apolo AB. Chandran EBA, et al. Among authors: redd b. Future Oncol. 2025 Jun;21(13):1625-1630. doi: 10.1080/14796694.2025.2497719. Epub 2025 May 27. Future Oncol. 2025. PMID: 40421891
Small cell carcinoma of the bladder: Review of pathogenesis, presentation, and management.
Simon NI, Kydd AR, Akbulut D, Takeda D, Del Rivero J, Merino M, Redd B, Lindenberg L, Mena E, Chandran E, Gurram S, Boudjadi S, Niglio S, Sharma P, Thomas A, Apolo AB. Simon NI, et al. Among authors: redd b. Bladder Cancer. 2025 Aug 18;11(3):23523735251370956. doi: 10.1177/23523735251370956. eCollection 2025 Jul-Sep. Bladder Cancer. 2025. PMID: 40842970 Free PMC article. Review.
A phase II study of lurbinectedin with or without avelumab in small cell carcinoma of the bladder (laser)-design and rationale.
Simon N, Chandran E, Atiq S, Kydd AR, Girardi D, Ley L, Cordes L, Wang TF, Boudjadi S, Stukes I, Smith E, Akbulut D, Niglio S, Patel R, Banday R, Redd B, Gurram S, Steinberg S, Apolo AB. Simon N, et al. Among authors: redd b. Future Oncol. 2025 Apr;21(10):1171-1177. doi: 10.1080/14796694.2025.2480534. Epub 2025 Mar 21. Future Oncol. 2025. PMID: 40116623
43 results